Form 8-K - Current report:
SEC Accession No. 0001193125-24-277937
Filing Date
2024-12-13
Accepted
2024-12-13 08:28:34
Documents
24
Period of Report
2024-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d916004d8k.htm   iXBRL 8-K 45426
2 EX-1.1 d916004dex11.htm EX-1.1 293495
3 EX-4.1 d916004dex41.htm EX-4.1 67642
4 EX-5.1 d916004dex51.htm EX-5.1 57035
5 EX-5.2 d916004dex52.htm EX-5.2 11593
6 EX-99.1 d916004dex991.htm EX-99.1 13561
7 EX-99.2 d916004dex992.htm EX-99.2 13737
12 GRAPHIC g916004g1212142443839.jpg GRAPHIC 1499
13 GRAPHIC g916004g1212142444142.jpg GRAPHIC 4284
14 GRAPHIC g916004g1212142444443.jpg GRAPHIC 5930
15 GRAPHIC g916004g1212143659488.jpg GRAPHIC 1561
  Complete submission text file 0001193125-24-277937.txt   813463

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA nams-20241211.xsd EX-101.SCH 3570
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nams-20241211_def.xml EX-101.DEF 14185
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nams-20241211_lab.xml EX-101.LAB 23101
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nams-20241211_pre.xml EX-101.PRE 15033
26 EXTRACTED XBRL INSTANCE DOCUMENT d916004d8k_htm.xml XML 5857
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41562 | Film No.: 241546882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)